©The Author(s) 2026.
World J Clin Cases. Feb 16, 2026; 14(5): 117981
Published online Feb 16, 2026. doi: 10.12998/wjcc.v14.i5.117981
Published online Feb 16, 2026. doi: 10.12998/wjcc.v14.i5.117981
Table 4 Duration of treatments of various antibiotic classes used
| Class of antibiotic | DOT |
| Aminoglycosides | 1413 |
| Anthelmintic | 71 |
| Antifungal: Antimetabolite | 79 |
| Antifungal: Azole | 804 |
| Antifungal: Echinocandin | 299 |
| Antifungal: Polyene | 449 |
| Antimalarial | 16 |
| Antitubercular drugs | 2455 |
| Antiviral: Direct-acting antivirals | 40 |
| Antiviral: HAART | 189 |
| Antiviral: Neuraminidase inhibitors | 114 |
| Antiviral: NS5 polymerase inhibitors | 92 |
| Antiviral: Nucleoside analogue | 285 |
| Beta lactamase inhibitor | 4452 |
| Carbapenems | 4587 |
| Cephalosporins | 3279 |
| Fluoroquinolones | 1640 |
| Folic acid synthesis Inhibitors | 910 |
| Glycopeptides | 2728 |
| Lincosamides | 604 |
| Macrolide | 562 |
| Monobactam | 169 |
| Nitrofurans | 195 |
| Nitroimidazoles | 1393 |
| Other antibiotics (unknown) | 1465 |
| Oxazolidonones | 1243 |
| Penicillins | 3907 |
| Phosphonates | 64 |
| Polymixins | 2322 |
| Rifamycins | 956 |
| Tetracyclines | 1229 |
- Citation: Pandy P, Singh H, Omar BJ, Kumari D, Panda PK. Clinical outcomes of multidrug-resistant organism infections in a tertiary care hospital in India. World J Clin Cases 2026; 14(5): 117981
- URL: https://www.wjgnet.com/2307-8960/full/v14/i5/117981.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v14.i5.117981